191 related articles for article (PubMed ID: 2545060)
1. [Immunobiologic activity of Bordetella pertussis strains defective in various virulence factors].
Smirnov VD; Chuprinina RP; Siundiukova RA; Maksiutov RV
Zh Mikrobiol Epidemiol Immunobiol; 1989 Mar; (3):8-10. PubMed ID: 2545060
[TBL] [Abstract][Full Text] [Related]
2. [A polyvalent complex of Bordetella pertussis antigens as the basis for an acellular pertussis vaccine].
Zakharova NS; Shmeleva EI; Remova TN; Bazhanova IG; Ozeretskovskaia MN; Mertsalova NU; Britsina MV; Ermolova EV; Zaĭtsev EM
Zh Mikrobiol Epidemiol Immunobiol; 1997; (3):70-2. PubMed ID: 9304336
[TBL] [Abstract][Full Text] [Related]
3. Immunoelectron microscopy of antigens of Bordetella pertussis using monoclonal antibodies to agglutinogens 2 and 3, filamentous haemagglutinin, pertussis toxin, pertactin and adenylate cyclase toxin.
Blom J; Heron I; Hendley JO
APMIS; 1994 Sep; 102(9):681-9. PubMed ID: 7946271
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the protective effects of the pertussis acellular vaccine with the component vaccine, which have different amounts of fimbriae, against the experimental aerosol infection of mice with Bordetella pertussis.
Morokuma K; Ginnaga A; Nishihara T; Tsunoda S; Furukawa M; Aihara K; Sakoh M
Dev Biol Stand; 1991; 73():223-32. PubMed ID: 1685713
[TBL] [Abstract][Full Text] [Related]
5. Bordetella pertussis and Bordetella parapertussis: two immunologically distinct species.
Khelef N; Danve B; Quentin-Millet MJ; Guiso N
Infect Immun; 1993 Feb; 61(2):486-90. PubMed ID: 8423077
[TBL] [Abstract][Full Text] [Related]
6. [Use of an immunoblotting method for identifying the individual proteins in the antigenic complexes of Bordetella pertussis].
Semina IE; Iankina ZK
Zh Mikrobiol Epidemiol Immunobiol; 1989 Mar; (3):78-81. PubMed ID: 2568040
[TBL] [Abstract][Full Text] [Related]
7. Pertussis toxin and extracytoplasmic adenylate cyclase as virulence factors of Bordetella pertussis.
Weiss AA; Hewlett EL; Myers GA; Falkow S
J Infect Dis; 1984 Aug; 150(2):219-22. PubMed ID: 6088647
[TBL] [Abstract][Full Text] [Related]
8. Characterization of mutant strains producing pertussis toxin cross reacting materials.
Sato Y; Sato H; Chazono M; Ginnaga A; Tamura C
Dev Biol Stand; 1991; 73():93-107. PubMed ID: 1778339
[TBL] [Abstract][Full Text] [Related]
9. [Modern strains of Bordetella pertussis: immunobiological properties and vaccine improvement].
Shinkarev AS; Mertsalova NU; Mazurova IK; Borisova OIu; Zakharova NS; Ozeretskovskaia MN; Zaĭtsev EM; Poddubikov AV; Britsina MV; Bazhanova IG
Zh Mikrobiol Epidemiol Immunobiol; 2007; (4):20-5. PubMed ID: 17886371
[TBL] [Abstract][Full Text] [Related]
10. Long-term human serum antibody responses after immunization with whole-cell pertussis vaccine in France.
Grimprel E; Bégué P; Anjak I; Njamkepo E; François P; Guiso N
Clin Diagn Lab Immunol; 1996 Jan; 3(1):93-7. PubMed ID: 8770511
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of an acellular pertussis vaccine composed of genetically inactivated pertussis toxin combined with filamentous hemagglutinin and pertactin in infants and children.
Podda A; Carapella De Luca E; Titone L; Casadei AM; Cascio A; Bartalini M; Volpini G; Peppoloni S; Marsili I; Nencioni L
J Pediatr; 1993 Jul; 123(1):81-4. PubMed ID: 8320630
[TBL] [Abstract][Full Text] [Related]
12. Role of pertussigen (pertussis toxin) on the mouse protective activity of vaccines made from Bordetella species.
Munoz JJ; Peacock MG
Microbiol Immunol; 1989; 33(4):341-55. PubMed ID: 2549344
[TBL] [Abstract][Full Text] [Related]
13. Pertussis whole cell vaccine: relation between intracerebral protection in mice and antibody response to pertussis toxin, filamentous hemagglutinin and adenylate cyclase.
Dellepiane NI; Manghi MA; Eriksson PV; di Paola G; Cangelosi A
Zentralbl Bakteriol; 1992 Jun; 277(1):65-73. PubMed ID: 1520970
[TBL] [Abstract][Full Text] [Related]
14. Molecular aspects of Bordetella pertussis pathogenesis.
Locht C
Int Microbiol; 1999 Sep; 2(3):137-44. PubMed ID: 10943406
[TBL] [Abstract][Full Text] [Related]
15. Filamentous hemagglutinin and pertussis toxin from Bordetella pertussis modulate immune responses to unrelated antigens.
McGuirk P; Johnson PA; Ryan EJ; Mills KH
J Infect Dis; 2000 Oct; 182(4):1286-9. PubMed ID: 10979938
[No Abstract] [Full Text] [Related]
16. Appearance of Bordetella pertussis strains not expressing the vaccine antigen pertactin in Finland.
Barkoff AM; Mertsola J; Guillot S; Guiso N; Berbers G; He Q
Clin Vaccine Immunol; 2012 Oct; 19(10):1703-4. PubMed ID: 22914363
[No Abstract] [Full Text] [Related]
17. Murine model for pertussis vaccine encephalopathy: role of the major histocompatibility complex; antibody to albumin and to Bordetella pertussis and pertussis toxin.
Steinman L; Weiss A; Adelman N; Lim M; Oehlert J; Zuniga R; Hewlett E; Falkow S
Dev Biol Stand; 1985; 61():439-46. PubMed ID: 2872126
[TBL] [Abstract][Full Text] [Related]
18. Cell surface antigens of Bordetella pertussis.
Parker CD; Branes LV; Armstrong SK; Frank DW; Cole A
Dev Biol Stand; 1985; 61():123-36. PubMed ID: 2872098
[TBL] [Abstract][Full Text] [Related]
19. Dermonecrotic toxin and tracheal cytotoxin, putative virulence factors of Bordetella avium.
Gentry-Weeks CR; Cookson BT; Goldman WE; Rimler RB; Porter SB; Curtiss R
Infect Immun; 1988 Jul; 56(7):1698-707. PubMed ID: 3384473
[TBL] [Abstract][Full Text] [Related]
20. Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens.
Macdonald-Fyall J; Xing D; Corbel M; Baillie S; Parton R; Coote J
Vaccine; 2004 Oct; 22(31-32):4270-81. PubMed ID: 15474718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
